Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells

By Takano M.   Hasegawa R.   Fukuda T.   Yumoto R.   Nagai J.   Murakami T.  

European Journal of Pharmacology, Vol. 358, Iss. 3, 1998-10 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells

By Zhou Yan-Gang   Li Kun-Yan   Li Huan-De  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 7, 2008-07 ,pp. : 697-703

Springer Publishing Company

Access to resources Recommend Favorite

Predicting P-Glycoprotein Effects on Oral Absorption: Correlation of Transport in Caco-2 with Drug Pharmacokinetics in Wild-Type and mdr1a(-/-) Mice in Vivo

By Collett Andrew   Tanianis-Hughes Jolanta   Hallifax David   Warhurst Geoff  

Pharmaceutical Research, Vol. 21, Iss. 5, 2004-05 ,pp. : 819-826

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers

By Zastre J.   Jackson J.   Bajwa M.   Liggins R.   Iqbal F.   Burt H.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 3, 2002-11 ,pp. : 299-309

Elsevier

Access to resources Recommend Favorite

P-glycoprotein Potentiates CYP3A4-mediated Drug Disappearance during Caco-2 Intestinal Secretory Detoxification

By Chan Lauretta M.S.   Cooper Anne E.   Dudley Adam L.J.   Ford Dianne   Hirst Barry H.  

Journal of Drug Targeting, Vol. 12, Iss. 7, 2004-08 ,pp. : 405-413

Informa Healthcare

Access to resources Recommend Favorite